Techniques for optimizing lead placement during sacral neuromodulation

2019 ◽  
Vol 31 (5) ◽  
pp. 1049-1051
Author(s):  
Nicole A. Dodge ◽  
Brian J. Linder
Keyword(s):  
Sacral Neuromodulation ◽  
Lead Placement

Utilization of CT for InterStim sacral neuromodulation lead placement in a patient with morbid obesity

2019 ◽  
Vol 30 (10) ◽  
pp. 1779-1781
Author(s):  
Sierra M. Jansen ◽  
Benjamin Giertych ◽  
Christine Heisler
Keyword(s):  
Morbid Obesity ◽  
Sacral Neuromodulation ◽  
Lead Placement

Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique

2019 ◽  
Vol 38 (6) ◽  
pp. 1595-1601 ◽  
Author(s):  
Sarah A. Adelstein ◽  
Wai Lee ◽  
Kevin Gioia ◽  
Dena Moskowitz ◽  
Kelsey Stamnes ◽  
...  
Keyword(s):  
Sacral Neuromodulation ◽  
Lead Placement ◽  
Placement Technique

Computed tomography-guided S3 lead placement for sacral neuromodulation

2012 ◽  
Vol 24 (2) ◽  
pp. 349-351 ◽  
Author(s):  
Christopher P. Chung ◽  
Paul A. Neese ◽  
Hoang Kim Le ◽  
Erin T. Bird
Keyword(s):  
Computed Tomography ◽  
Sacral Neuromodulation ◽  
Lead Placement

PD27-04 OUTCOMES OF BILATERAL LEAD PLACEMENT FOR STAGE I OF SACRAL NEUROMODULATION TRIAL

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Adrienne Quirouet ◽  
Ashley King ◽  
Howard Goldman ◽  
Raymond Rackley ◽  
Courtenay Moore ◽  
...  
Keyword(s):  
Sacral Neuromodulation ◽  
Stage I ◽  
Lead Placement

scholarly journals The effect of the number of active electrode poles during tined lead placement on long‐term efficacy of sacral neuromodulation in patients with faecal incontinence

2020 ◽  
Vol 22 (12) ◽  
pp. 2140-2145
Author(s):  
R. Assmann ◽  
S. O. Breukink ◽  
S. A. P. Caubergh ◽  
L. P. S. Stassen ◽  
S. M. J. Kuijk ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation ◽  
Active Electrode ◽  
Term Efficacy ◽  
Lead Placement ◽  
Tined Lead

Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?

2011 ◽  
Vol 30 (8) ◽  
pp. 1489-1492 ◽  
Author(s):  
Kenneth M. Peters ◽  
Kim A. Killinger ◽  
Judith A. Boura
Keyword(s):  
Sacral Neuromodulation ◽  
Positive Outcomes ◽  
Sensory Testing ◽  
Lead Placement

PD36-06 LOWER RISK OF LEAD REVISION BASED ON “OPTIMAL”LEAD PLACEMENT DURING STAGE 1 SACRAL NEUROMODULATION

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
javier Pizarro-Berdichevsky ◽  
Adrienne Quirouet ◽  
Marisa M Clifton ◽  
Bradley C Gill ◽  
Elodi J Dielubanza ◽  
...  
Keyword(s):  
Lower Risk ◽  
Sacral Neuromodulation ◽  
Lead Placement ◽  
Stage 1

PD54-03 OPTIMIZING LEAD PLACEMENT DURING STAGED SACRAL NEUROMODULATION (SNM): FACTORS ASSOCIATED WITH PROGRESSION TO STAGE 2

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Sarah A Adelstein ◽  
Kevin Gioia ◽  
Jonathan Wingate ◽  
Alvaro Lucioni ◽  
Kathleen C Kobashi ◽  
...  
Keyword(s):  
Sacral Neuromodulation ◽  
Factors Associated ◽  
Lead Placement

Reduced radiation fluoroscopy technique for implantation of sacral neuromodulation

2021 ◽  
pp. 205141582110029
Author(s):  
Jason Groegler ◽  
Mohammad Hajiha ◽  
Hillary Wagner ◽  
Forrest Jellison ◽  
Akin S Amasyali ◽  
...  
Keyword(s):  
Radiation Exposure ◽  
Operating Room ◽  
Low Dose ◽  
Sacral Neuromodulation ◽  
Level Of Evidence ◽  
Lead Placement ◽  
Significant Difference ◽  
Fluoroscopic Imaging ◽  
Effects Of Radiation ◽  
Operating Room Staff

Introduction: Sacral neuromodulation (SNM) is a Food and Drug Administration–approved treatment option for urinary urgency and fecal incontinence. Fluoroscopic imaging is used at various steps during lead placement, which exposes the operating room staff and patient to the harmful effects of radiation. The aim of this study is to describe a reduced radiation technique during lead placement for treatment with SNM. Methods: A retrospective cohort of 51 consecutive patients who underwent lead insertion and SNM placement at a single academic institution were investigated. Reduced fluoroscopy (RF; n=11) involved C-arm settings to 1 pulse/second and an activated “low-dose” setting, while conventional fluoroscopy (CF; n=40) involved 30 pulses/second and a deactivated “low-dose” setting. The automatic brightness control and collimation were used optionally in both groups. Comparison of imaging quality, fluoroscopy settings, and radiation exposure during RF and CF was performed. Results: RF settings resulted in significant reduction of radiation compared to CF settings, including the fluoroscopy time (8.61 vs. 48.16 seconds; p<0.001), dose (2.66 vs. 26.25 mGy; p=0.001), and current (1.67 vs. 4.18 mAs; p<0.001). There was no significant difference in total operative time (59.18 vs. 61.33 minutes; p=0.77) and the rate of progression from stage 1 to stage 2 during follow-up (75% vs. 84%; p=0.55). Conclusions: Lead placement for treatment with SNM can be achieved using RF settings without compromising clinical outcomes. Applying the RF technique reduces overall radiation exposure to the patient and the operating room staff. Further validation of RF in a larger prospective cohort study is needed. Level of evidence: Level 4.

Sign in / Sign up

Export Citation Format

Share Document